Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation Prior to Botulinum Toxin for Spasmodic Dysphonia
NCT05892770Phase 2Completed
- Sponsor
- University of Florida
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of zinc gluconate in Spasmodic dysphonia (SD), sponsored by University of Florida. Started Aug 2023; status: completed.
02
Drugs
zinc gluconate
03
Conditions
Spasmodic dysphonia (SD)
Beyond the preview
Go deeper on NCT05892770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05892770.